Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel XR monotherapy vs combination with lithium in bipolar depression
NCT00883493Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 3, randomised, open-label trial of quetiapine in bipolar disorder (BD), sponsored by AstraZeneca. Primary endpoint: Montgomery-Asberg Depression Rating Scale at 8 weeks. Started Apr 2009; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00883493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00883493.